» Authors » C Mayo

C Mayo

Explore the profile of C Mayo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 284
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Valtuena F, Ortega-Olivencia A, Rodriguez-Riano T, Perez-Bote J, Mayo C
Plant Biol (Stuttg) . 2012 Jul; 15(2):328-34. PMID: 22823112
Several hypotheses have been proposed to explain the pattern of pollinator visits to vertical inflorescences. These range from a response to a pattern of resources to merely instinctive behaviour. In...
2.
Teuffel O, Cheng S, Ethier M, Diorio C, Martino J, Mayo C, et al.
Support Care Cancer . 2012 Feb; 20(11):2755-64. PMID: 22350594
Purpose: To describe anticipated health-related quality of life (HRQL) for different hypothetical strategies of febrile neutropenia (FN) management in adult cancer patients. Methods: Seventy-eight adult cancer patients were enrolled. Our...
3.
Cheng S, Teuffel O, Ethier M, Diorio C, Martino J, Mayo C, et al.
Br J Cancer . 2011 Jun; 105(5):606-11. PMID: 21694729
Background: To describe (1) anticipated health-related quality of life during different strategies for febrile neutropaenia (FN) management and (2) attributes of those preferring inpatient management. Methods: Respondents were parents of...
4.
Mayo C
Med Chir Trans . 2010 Oct; 16(Pt 2):359-66. PMID: 20895578
No abstract available.
5.
Mayo C
Med Chir Trans . 2010 Oct; 12(Pt 1):12-26. PMID: 20895437
No abstract available.
6.
Mayo C
Med Chir Trans . 2010 Oct; 11(Pt 1):54-234.1. PMID: 20895410
No abstract available.
7.
Mayo C
Prov Med Surg J . 2010 Aug; 14(20):538-9. PMID: 20794880
No abstract available.
8.
9.
Mayo C
Br Med J . 2010 Aug; 1(652):726-7. PMID: 20747126
No abstract available.
10.
Porta R, Sanchez-Torres J, Paz-Ares L, Massuti B, Reguart N, Mayo C, et al.
Eur Respir J . 2010 Jul; 37(3):624-31. PMID: 20595147
Median survival of patients with brain metastases from nonsmall cell lung cancer (NSCLC) is poor and more effective treatments are urgently needed. We have evaluated the efficacy of erlotinib in...